Free Trial
NASDAQ:QLGN

Qualigen Therapeutics (QLGN) Stock Price, News & Analysis

Qualigen Therapeutics logo
$3.76 +0.12 (+3.15%)
As of 05/28/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Qualigen Therapeutics Stock (NASDAQ:QLGN)

Key Stats

Today's Range
$3.66
$3.74
50-Day Range
$3.00
$3.94
52-Week Range
$2.85
$29.44
Volume
7,921 shs
Average Volume
113,301 shs
Market Capitalization
$2.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Receive QLGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

QLGN Stock News Headlines

Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
See More Headlines

QLGN Stock Analysis - Frequently Asked Questions

Qualigen Therapeutics' stock was trading at $4.21 at the beginning of the year. Since then, QLGN shares have decreased by 10.6% and is now trading at $3.7650.
View the best growth stocks for 2025 here
.

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) released its earnings results on Tuesday, August, 15th. The company reported ($34.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($26.00) by $8.50. The company had revenue of $1.63 million for the quarter, compared to analyst estimates of $1.60 million.

Shares of Qualigen Therapeutics reverse split on Tuesday, November 5th 2024. The 1-50 reverse split was announced on Friday, November 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 4th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Qualigen Therapeutics' top institutional investors include FNY Investment Advisers LLC (1.03%). Insiders that own company stock include Michael S Poirier and Amy S Broidrick.
View institutional ownership trends
.

Shares of QLGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Qualigen Therapeutics investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), Bank of America (BAC), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/15/2023
Today
5/29/2025
Next Earnings (Estimated)
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QLGN
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.98 million
Price / Cash Flow
N/A
Book Value
($20.31) per share
Price / Book
-0.19

Miscellaneous

Free Float
723,000
Market Cap
$2.77 million
Optionable
Not Optionable
Beta
-0.07
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:QLGN) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners